CA3189432A1
(en )
2022-02-03
Conjugated hepcidin mimetics
EP4501952A2
(en )
2025-02-05
Conjugated hepcidin mimetics
JP2011511753A5
(https= )
2012-11-08
AU2018210174A1
(en )
2019-07-25
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US20240293511A1
(en )
2024-09-05
Hepcidin mimetics for treatment of hereditary hemochromatosis
AU2016293619A1
(en )
2018-02-01
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
WO2017117411A1
(en )
2017-07-06
Analogues of hepcidin mimetics with improved in vivo half lives
JP2020502051A5
(https= )
2020-12-03
CN114341161A
(zh )
2022-04-12
白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
HUE035378T2
(en )
2018-05-02
Compstatin with peptide framework and C-terminal modifications
CA3214153A1
(en )
2022-10-06
Conjugated hepcidin mimetics
CA2931694C
(en )
2020-12-01
Fatty acid derivatives of dimeric peptide ligands of psd-95 and use thereof for treating excitotoxic disease
WO2022212698A1
(en )
2022-10-06
Conjugated hepcidin mimetics
AU2010216372A1
(en )
2011-09-15
Cytotoxic conjugates having neuropeptide Y receptor binding compound
JPWO2025142861A5
(https= )
2025-11-26
EP2848629B1
(en )
2017-09-06
Synthetic peptides wtih a non-narcotic type of analgesic effect
SK150196A3
(en )
1997-06-04
Peptides with immunomodulatory effects, pharmaceutical formulations containing them and their use
JP2014509604A
(ja )
2014-04-21
エイズの治療のための、ポリアニオン性ポリペプチドと結合しているcd4受容体由来ペプチドを含んでなる新規コンジュゲート分子
CN119630790A
(zh )
2025-03-14
新型lrp1结合肽
WO2024043249A1
(ja )
2024-02-29
環状ペプチドまたはその塩、およびmdmx阻害剤
JPWO2023190812A5
(https= )
2024-03-08
JP2005060315A
(ja )
2005-03-10
製剤組成物
US20030176354A1
(en )
2003-09-18
Therapeutic uses of tri-, tetra-, penta-, and polypeptides
JP5354206B2
(ja )
2013-11-27
抗菌性ペプチド
WO2026068492A1
(en )
2026-04-02
Compounds comprising modified w peptide